항암 활성을 갖는 신규한 6-(피리딘-3-일)피리미딘 화합물
    2.
    发明公开
    항암 활성을 갖는 신규한 6-(피리딘-3-일)피리미딘 화합물 有权
    新的6-(吡啶-3-基)吡啶衍生物作为反应剂

    公开(公告)号:KR1020100045694A

    公开(公告)日:2010-05-04

    申请号:KR1020080104760

    申请日:2008-10-24

    Abstract: PURPOSE: A novel 6-(pyridine-3-yl)primidine compound is provided to ensure anti-cancer activity and suppress melanoma development. CONSTITUTION: A novel 6-(pyridine-3-yl)pyrimidine compound is denoted by chemical formula 1. In chemical formula 1, R1 is hydrogen atom or C1-C6 alkyl group; R2 is hydrogen atom, halogen atom, phenyl amino group, phenyl group, acetylphenyl group, acetyl aminophenyl group, or pyridyl group; and Y is -N(R')C(O)-, -N(R')C(O)N(R")-, or -N(R')C(O)N(R")C(O)-. An anti-cancer drug contains the 6-(pyridine-3-yl)pyrimidine compound or pharmaceutically acceptable salt thereof.

    Abstract translation: 目的:提供新的6-(吡啶-3-基)基基配合物以确保抗癌活性并抑制黑素瘤发展。 构成:化学式1表示新的6-(吡啶-3-基)嘧啶化合物。在化学式1中,R 1为氢原子或C 1 -C 6烷基; R2是氢原子,卤素原子,苯基氨基,苯基,乙酰基苯基,乙酰基氨基苯基或吡啶基; 并且Y是-N(R')C(O) - , - N(R')C(O)N(R“) - 或-N(R')C(O)N(R” O) - 。 抗癌药含有6-(吡啶-3-基)嘧啶化合物或其药学上可接受的盐。

    시스-디(티오시아나토)-N,N'-비스(2,2'-비피리딜-4,4'-디카르복시산)루테늄(Ⅱ)의 개선된 제조방법
    3.
    发明授权
    시스-디(티오시아나토)-N,N'-비스(2,2'-비피리딜-4,4'-디카르복시산)루테늄(Ⅱ)의 개선된 제조방법 有权
    顺式二硫代氨基-N,N'-双-2,2'-联吡啶-4,4'-二羧酸钌(II)的改进方法

    公开(公告)号:KR100847554B1

    公开(公告)日:2008-07-21

    申请号:KR1020060119502

    申请日:2006-11-30

    Abstract: 본 발명은 시스-디(티오시아나토)-N,N'-비스(2,2'-비피리딜-4,4'-디카르복시산)루테늄(Ⅱ)의 개선된 제조방법에 관한 것으로서, 더욱 상세하게는 디메틸포름아미드(DMF) 또는 디메틸포름아미드(DMF) 수용액을 반응용매로 사용하고, 반응물질로서 루테늄(Ⅲ) 클로라이드 수화물, 2,2'-비피리딘-4,4'-디카르복시산 및 티오시안산 알칼리금속염을 한꺼번에 반응용기에 넣고 마이크로파를 조사하는 조건에서 환류 반응시켜 제조하며, 반응이 완결되면 반응용액에 염산 또는 황산의 무기산 수용액을 첨가하여 반응용액의 pH를 2 내지 5로 조절하는 간단한 분리공정을 수행하여 염료감응 태양전지용 N3 염료로 잘 알려져 있는 시스-디(티오시아나토)-N,N'-비스(2,2'-비피리딜-4,4'-디카르복시산)루테늄(Ⅱ)을 고체 상으로 수득하는 방법에 관한 것이다.
    N3 염료, 염료감응 태양전지, 시스-디(티오시아나토)-N,N'-비스(2,2'-비피리딜-4,4'-디카르복시산)루테늄(Ⅱ), 루테늄(Ⅲ) 클로라이드 수화물, 2,2'-비피리딘-4,4'-디카르복시산, 티오시안산 알칼리금속염

    T-형 칼슘 채널 차단제로 유용한 트리아졸 유도체
    5.
    发明公开
    T-형 칼슘 채널 차단제로 유용한 트리아졸 유도체 失效
    T型钙通道阻塞剂的三唑衍生物

    公开(公告)号:KR1020080105463A

    公开(公告)日:2008-12-04

    申请号:KR1020070053068

    申请日:2007-05-31

    Abstract: A triazole derivative useful as a T-type calcium channel blocker, and a pharmaceutical composition containing the derivative rae provided to inhibit the calcium channel of cell membranes, thereby preventing and treating the diseases such as brain disease, heart disease, neurogenic pain and cancer disease. A triazole derivative is represented by the formula 1, wherein R1 is phenyl group, a benzimidazole group, or a benzimidazole C1-C8 alkyl group; R2 is H, a C1-C8 alkyl group, a C1-C20 alkanoyl group, a phenyl group, a benzoyl group, or a thiophenecarbonyl group; R3 is H, or an N-phenylacetamide group; and the benzene ring of a phenyl group, a benzoyl group, a benzimidazole group and an N-phenylacetamide group can be substituted with 1-4 substituents selected from a halogen atom, a nitro group, a C1-C8 alkyl group, a C1-C8 alkoxy group and a C1-C8 haloalkyl group.

    Abstract translation: 可用作T型钙通道阻断剂的三唑衍生物和含有衍生物的药物组合物,其用于抑制细胞膜的钙通道,从而预防和治疗脑疾病,心脏病,神经源性疼痛和癌症疾病 。 三唑衍生物由式1表示,其中R1是苯基,苯并咪唑基或苯并咪唑C1-C8烷基; R2是H,C1-C8烷基,C1-C20烷酰基,苯基,苯甲酰基或噻吩羰基; R3是H或N-苯基乙酰胺基团; 苯基,苯甲酰基,苯并咪唑基和N-苯基乙酰胺基的苯环可以被1-4个选自卤素原子,硝基,C1-C8烷基,C1- C8烷氧基和C1-C8卤代烷基。

    시스-디(티오시아나토)-N,N'-비스(2,2'-비피리딜-4,4'-디카르복시산)루테늄(Ⅱ)의 개선된 제조방법
    6.
    发明公开
    시스-디(티오시아나토)-N,N'-비스(2,2'-비피리딜-4,4'-디카르복시산)루테늄(Ⅱ)의 개선된 제조방법 有权
    制备CIS-DI(THIOCYANATO)-N,N'-二(2,2'-联吡啶-4,4'-二羧酸)钌(II)的改进方法

    公开(公告)号:KR1020080049197A

    公开(公告)日:2008-06-04

    申请号:KR1020060119502

    申请日:2006-11-30

    CPC classification number: C07F15/0053 H01G9/2059 Y02E10/542

    Abstract: A method for preparing cis-di(thiocyanato)-N,N-bis(2,2-bipyridyl-4,4-dicarboxylic acid)ruthenium(II)(N3) is provided to improve the yield significantly and mass-produce an N3 dye industrially. A method for preparing cis-di(thiocyanato)-N,N-bis(2,2-bipyridyl-4,4-dicarboxylic acid)ruthenium(II) comprises a step of subjecting a ruthenium(III) chloride hydrate, 2,2'-bipyridin-4,4'-dicarboxylic acid and an alkali metal salt of thiocyanic acid to reflux reaction using dimethyl formamide(DMF) or an aqueous solution of the DMF as a solvent in a microwave reactor irradiating microwave having a wavelength of 355W. Further, 5 to 95 vol.% of dimethyl formamide is comprised in the aqueous solution of the DMF.

    Abstract translation: 提供顺式 - 二(氰硫基)-N,N-双(2,2-联吡啶-4,4-二羧酸)钌(II)(N3)的制备方法,以显着提高产率,大量产生N3 工业染料。 顺式 - 二(氰硫基)-N,N-双(2,2-联吡啶基-4,4-二羧酸)钌(II)的制备方法包括将氯化钌(III)水合物2,2 ' - 联吡啶-4,4'-二羧酸和硫氰酸碱金属盐反应,在微波反应器中照射波长355W的微波,使用二甲基甲酰胺(DMF)或DMF的水溶液作为溶剂回流反应。 此外,在DMF的水溶液中含有5〜95体积%的二甲基甲酰胺。

Patent Agency Ranking